| First Author | Huber S | Year | 2008 |
| Journal | PLoS One | Volume | 3 |
| Issue | 10 | Pages | e3302 |
| PubMed ID | 18827879 | Mgi Jnum | J:144430 |
| Mgi Id | MGI:3830923 | Doi | 10.1371/journal.pone.0003302 |
| Citation | Huber S, et al. (2008) P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg. PLoS One 3(10):e3302 |
| abstractText | CD4+CD25+ regulatory T cells (Treg) are important mediators of immune tolerance. A subset of Treg can be generated in the periphery by TGF-beta dependent conversion of conventional CD4+CD25- T cells into induced Treg (iTreg). In chronic viral infection or malignancy, such induced iTreg, which limit the depletion of aberrant or infected cells, may be of pathogenic relevance. To identify potential targets for therapeutic intervention, we investigated the TGF-beta signaling in Treg. In contrast to conventional CD4+ T cells, Treg exhibited marked activation of the p38 MAP kinase pathway. Inhibition of p38 MAP kinase activity prevented the TGF-beta-dependent conversion of CD4+CD25- T cells into Foxp3+ iTreg in vitro. Of note, the suppressive capacity of nTreg was not affected by inhibiting p38 MAP kinase. Our findings indicate that signaling via p38 MAP kinase seems to be important for the peripheral generation of iTreg; p38 MAP kinase could thus be a therapeutic target to enhance immunity to chronic viral infection or cancer. |
